Position in CYTK
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$580,667
+$36,765 QoQ
Shares Held
8,810
+2.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qsemble Capital Management, LP holds $7,848,553 across 6 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
31,633 | $2,356,025 | |
| 2 | INSM |
INSMED Inc
|
21,148 | $2,254,799 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
47,971 | $1,871,348 | |
| 4 | RPRX |
Royalty Pharma plc
|
10,675 | $598,547 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
5,639 | $459,634 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
3,887 | $308,200 |
All Filings in CYTK
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $580,667 | 8,810 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $543,902 | 8,560 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $333,332 | 6,065 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $315,210 | 7,843 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $260,836 | 5,545 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||